Patent · US Active

Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity

US12297432B2 · kind B2 · utility

0Cited by

226References

9Claims

0Family size

Assignee

Takeda Pharmaceuticals U.S.A., Inc. · US

Inventors

Nessan Bermingham · London, GB
Brian Bettencourt · Groton, US
Pei Ge · Cambridge, US

Key dates

Filing date	Jun 16, 2022
Grant date	May 13, 2025
Priority date	—
Expiry date	Jun 27, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/35
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present disclosure features useful compositions and methods to treat nucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.